Clinical Trials

NCT04725630 | COMPLETED | NA
597 participants

Healthy Food Prescription Incentive Program

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-26
Start Date:
2021-05-29
Completion:
2024-02-28
Conditions
  • Diet, Healthy
  • Diabetes Mellitus, Type 2
  • Diabetes Complications
Interventions
  • BEHAVIORAL
No Results Yet
NCT04365101 | TERMINATED | PHASE1/PHASE2
7 participants

Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-26
Start Date:
2020-09-02
Completion:
2021-08-30
Conditions
  • Coronavirus
  • Coronavirus Infection
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • Pneumonia
  • Pneumonia, Viral
  • Lung Diseases
  • Respiratory Tract Disease
  • Respiratory Tract Infections
  • Coronaviridae Infections
  • Nidovirales Infections
  • RNA Virus Infections
  • Virus Disease
  • Immunologic Disease
  • ARDS
  • Immunologic Factors
  • Physiological Effects of Drugs
  • Antiviral Agents
  • Anti-infective Agents
  • Analgesics
  • Antimetabolites, Antineoplastic
Interventions
  • BIOLOGICAL
NCT04205409 | COMPLETED | PHASE2
20 participants

Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-26
Start Date:
2020-06-05
Completion:
2024-09-20
Conditions
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Follicular Lymphoma
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3 Follicular Lymphoma
  • Recurrent Grade 3a Follicular Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Recurrent Non-Hodgkin Lymphoma
  • Recurrent Plasma Cell Myeloma
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Follicular Lymphoma
  • Refractory Marginal Zone Lymphoma
  • Refractory Non-Hodgkin Lymphoma
  • Refractory Plasma Cell Myeloma
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
Interventions
  • BIOLOGICAL
NCT04165096 | COMPLETED | PHASE2
128 participants
Previous
Sorted by latest updates
Next
Showing 40 trials per page